Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
โ Scribed by Romeo, Stefano (author);Kozlitina, Julia (author);Xing, Chao (author);Pertsemlidis, Alexander (author);Cox, David (author);Pennacchio, Len A. (author);Boerwinkle, Eric (author);Cohen, Jonathan C. (author);Hobbs, Helen H. (author)
- Book ID
- 109914348
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 491 KB
- Volume
- 40
- Category
- Article
- ISSN
- 1061-4036
- DOI
- 10.1038/ng.257
No coin nor oath required. For personal study only.
โฆ Synopsis
Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem of unknown etiology that varies in prevalence among ancestry groups. To identify genetic variants contributing to differences in hepatic fat content, we carried out a genome-wide association scan of nonsynonymous sequence variations (n = 9,229) in a population comprising Hispanic, African American and European American individuals. An allele in PNPLA3 (rs738409[G], encoding I148M) was strongly associated with increased hepatic fat levels (P = 5.9 ร 10 -10 ) and with hepatic inflammation (P = 3.7 ร 10 -4 ). The allele was most common in Hispanics, the group most susceptible to NAFLD; hepatic fat content was more than twofold higher in PNPLA3 rs738409[G] homozygotes than in noncarriers. Resequencing revealed another allele of PNPLA3 (rs6006460[T], encoding S453I) that was associated with lower hepatic fat content in African Americans, the group at lowest risk of NAFLD. Thus, variation in PNPLA3 contributes to ancestry-related and inter-individual differences in hepatic fat content and susceptibility to NAFLD.
๐ SIMILAR VOLUMES
Nonalcoholic fatty liver disease (NAFLD) is a burgeoning medical problem that affects 20%-34% of the population in Western countries. 1 Although the prevalence of NAFLD is somewhat lower in Asia, the frequency is increasing, and the disorder is now being seen in younger individuals. 2,3 NAFLD is a m
Single nucleotide polymorphisms (SNPs) near 7 loci have been associated with liver function tests or with liver steatosis by magnetic resonance spectroscopy. In this study we aim to test whether these SNPs influence the risk of histologically-confirmed nonalcoholic fatty liver disease (NAFLD). We te
Genome-wide association studies identified single-nucleotide polymorphisms (SNPs) that are associated with increased hepatic fat or elevated liver enzymes, presumably reflecting nonalcoholic fatty liver disease (NAFLD). To investigate whether these SNPs are associated with histological severity of N